The US Neurodegenerative Disease Market segment analysis categorizes therapies into disease-modifying drugs, symptomatic treatments, combination therapies, and supportive care. Disease-modifying treatments, including gene therapies and monoclonal antibodies, are increasingly adopted for their ability to slow disease progression. Symptomatic treatments continue to manage motor and cognitive...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt